High-dose influenza vaccine shows no additional benefit for heart disease patients

News Launch

Friday, December 4, 2020

NIH-funded review finds increased dose is not a lot more productive at reducing critical flu issues in this substantial-danger group.

Large-dose influenza (usually identified as flu) vaccines are no better than common-dose influenza vaccines in reducing deaths and hospitalizations among individuals with underlying coronary heart condition, according to a significant review publishing in JAMA. The results do not improve perfectly-established results about the value of an yearly influenza vaccine for persons with coronary heart condition and other serious sicknesses, and do not improve the recommendation for an yearly influenza vaccine for most persons. 

The review was funded by the Countrywide Coronary heart, Lung, and Blood Institute (NHLBI), part of the Countrywide Institutes of Well being, and appears on the web on December 4.

“Getting a vaccine is even a lot more vital than standard this 12 months, as persons with COVID-19 who get the flu are at increased danger for a lot more critical issues,” reported Lawton S. Cooper, M.D., M.P.H., a single of the study’s co-authors and a researcher with the Scientific Purposes and Avoidance Department, Division of Cardiovascular Sciences, NHLBI. “People should comply with the direction of their health care supplier as to which flu vaccine, substantial or low dose, is better for them, but having the flu shot is a lot more critical than which dose.”

Scientists have identified for some time that persons with cardiovascular condition are at increased danger for establishing critical issues from influenza, which includes coronary heart assaults, hospitalizations for coronary heart failure, and death. As a end result, experts have strongly suggested that this group get an influenza vaccine, and at the very least a single review has advised that a substantial-dose edition could possibly aid decrease these issues a lot more than the common-dose vaccine.

To identify if there is reward in the increased dose, the NHLBI funded the Influenza Vaccine to Correctly Stop Cardio Thoracic Activities and Decompensated coronary heart failure (INVESTED) trial, a randomized, double-blind trial executed at 157 health care centers in the United States and Canada around a few influenza seasons. The trial, which was released in September 2016, included a full of 5,260 individuals who had been not long ago hospitalized for a cardiovascular party, which includes coronary heart attack within just the earlier 12 months or coronary heart failure within just the earlier two decades.

Each individual participant also had a single or a lot more further danger components for cardiovascular disease—for case in point, they had been age 65 or more mature, smoked, or had style 2 diabetic issues, obesity, kidney condition, peripheral artery condition, or a record of stroke.

At the conclusion of the review, the composite full of hospitalizations and deaths was approximately equivalent for equally flu vaccine groups. The scientists noticed 883 hospitalizations because of to cardiovascular or pulmonary causes and ninety two deaths from any cause in the substantial-dose vaccine group, while they saw 846 hospitalizations for these functions and seventy eight deaths from any cause in the common-dose vaccine group. The change was not statistically considerable.

Orly Vardeny, Pharm.D., M.S., lead researcher of the review and associate professor of medication at the University of Minnesota’s Healthcare School and College or university of Pharmacy, Minneapolis, reported there are a few of achievable explanations for the results. “First, we enrolled persons at substantial danger for coronary heart and lung-associated hospitalizations,” she reported, “so it’s achievable that the incremental reward of a single vaccine around the other would not have conquer the substantial underlying danger in this populace.” Even though there had been many hospitalizations through the trial, only a small amount had been discovered as brought about by influenza, hence yet another chance is that considering the fact that all individuals received the influenza vaccine, equally the substantial- and low-dose formulas in the same way lowered their danger for coronary heart and lung hospitalizations, Vardeny discussed.

Even though there had been couple of vaccine-associated side effects in both group, individuals who received substantial-dose vaccines tended to have a lot more regular injection-associated side effects, these types of as soreness, swelling, and muscle mass aches.

“It’s critical to bear in mind that all individuals in INVESTED received a vaccination, and that equally vaccine formulations had been typically perfectly tolerated with quite couple of individuals dealing with significant adverse reactions, with no change between groups,” reported Scott Solomon, M.D., review co-chief and professor of medication at Harvard Healthcare School. “Unfortunately, many substantial-danger cardiovascular individuals don’t get vaccinated at all. For reducing hospitalizations because of to coronary heart and lung issues, just having vaccinated with any influenza vaccine may well significantly decreased danger in our substantial-danger individuals.”

The scientists pointed out caveats in the review, which includes its concentrate on individuals with a substantial danger for cardiovascular condition, use of vaccine formulations out there through the 2016-17, 2017-eighteen, and 2018-19 influenza seasons, and use of vaccines that had been prepared in rooster eggs. The scientists reported upcoming scientific studies should analyze no matter if other styles of flu vaccine may well be a lot more protective for individuals with substantial-danger circumstances or no matter if a substantial-dose vaccine positive aspects low-danger cardiac individuals a lot more.

This review is supported by grants from the NHLBI (U01HL130163 and U01HL130204).

EDITOR’S Take note: The Countrywide Influenza Vaccination Week, noticed from December six-twelve, highlights the value of influenza vaccination.

About the Countrywide Coronary heart, Lung, and Blood Institute (NHLBI): NHLBI is the international chief in conducting and supporting research in coronary heart, lung, and blood conditions and sleep ailments that developments scientific knowledge, increases community health, and saves life. For a lot more details, visit 

About the Countrywide Institutes of Well being (NIH):
NIH, the nation’s health care research agency, includes 27 Institutes and Centers and is a component of the U.S. Section of Well being and Human Solutions. NIH is the major federal agency conducting and supporting standard, scientific, and translational health care research, and is investigating the causes, treatments, and cures for equally widespread and rare conditions. For a lot more details about NIH and its packages, take a look at www.nih.gov.

NIH…Turning Discovery Into Well being®


Influence of substantial-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in individuals with substantial-danger cardiovascular condition: a randomized scientific trial.” DOI: ten.1001/jama.2020.23649.